Skip to main content
Premium Trial:

Request an Annual Quote

Wellington Management Reports 11.5 Percent Stake in Celera

NEW YORK (GenomeWeb News) – Boston-based investment advisor Wellington Management Company owns an 11.53 percent stake in Celera, according to a US Securities and Exchange Commission filing today.
 
According to the 13G/A filing, Wellington, in its capacity as an investment advisor, owns 9,094,951 shares on behalf of clients of the firm. It noted in the filing that “no such client is known to have such right of power with respect to more than five percent” of Celera’s common stock.
 
Wellington is among the top institutional holders of Celera’s common stock. According to a recent filing by Celera, Fidelity Management & Research holds a nearly 13 percent stake in the firm, while AXA Assurances IARD Mutuelle owns a 9.5 percent stake, and Capital Research Global Investors holds a share of 7.2 percent.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.